nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adult-onset Still's disease
|
Gerfaud-Valentin, Mathieu |
|
2014 |
13 |
7 |
p. 708-722 15 p. |
artikel |
2 |
Biotherapies in Behçet's disease
|
Comarmond, Cloé |
|
2014 |
13 |
7 |
p. 762-769 8 p. |
artikel |
3 |
Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?
|
Burbelo, Peter D. |
|
2014 |
13 |
7 |
p. 756-761 6 p. |
artikel |
4 |
Impact of autoantibody glycosylation in autoimmune diseases
|
Goulabchand, Radjiv |
|
2014 |
13 |
7 |
p. 742-750 9 p. |
artikel |
5 |
Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature
|
Zard, Emilie |
|
2014 |
13 |
7 |
p. 730-735 6 p. |
artikel |
6 |
On the relationship between human papilloma virus vaccine and autoimmune diseases
|
Pellegrino, Paolo |
|
2014 |
13 |
7 |
p. 736-741 6 p. |
artikel |
7 |
Optimizing outcome in SLE: treating-to-target and definition of treatment goals
|
Doria, Andrea |
|
2014 |
13 |
7 |
p. 770-777 8 p. |
artikel |
8 |
Oral cobalamin (vitamin B12) therapy in pernicious anemia
|
Andrès, Emmanuel |
|
2014 |
13 |
7 |
p. 778- 1 p. |
artikel |
9 |
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must
|
Moroni, Gabriella |
|
2014 |
13 |
7 |
p. 723-729 7 p. |
artikel |
10 |
The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper
|
Fiorino, Gionata |
|
2014 |
13 |
7 |
p. 751-755 5 p. |
artikel |
11 |
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome
|
Cervera, Ricard |
|
2014 |
13 |
7 |
p. 699-707 9 p. |
artikel |
12 |
Treatment of pernicious anemia: Which is the best option?
|
Bizzaro, Nicola |
|
2014 |
13 |
7 |
p. 779- 1 p. |
artikel |